Disclosed herein is a multi-layered composite thin film material formed from graphene quantum dots (GQDs) and metal nanocrystals in a layer-by-layer design, wherein the metal nanocrystals can be selected from the group consisting of Ru, Rh, Os, Ir, Pd, Au, Ag and Pt. In a preferred embodiment, the multi-layered composite thin film material is prepared via a facile, green, and easily accessible layer-by-layer (LbL) self-assembly strategy. In this strategy, positively charged GOQDs and negatively charged metal nanocrystals are alternately and uniformly integrated with each other in a “face-to-face” stacked fashion under substantial electrostatic attractive interaction, and then the obtained GOQDs/metal composite thin film is calcined into GQDs/metal composite thin film. The composite thin film material disclosed herein may be used to catalyse a wide range or reactions, including selective reduction of aromatic nitro compounds in water and electrocatalytic oxidation of methanol at ambient conditions.

Disclosed herein is a multi-layered composite thin film material formed from graphene quantum dots (GQDs) and metal nanocrystals in a layer-by-layer design, wherein the metal nanocrystals can be selected from the group consisting of Ru, Rh, Os, Ir, Pd, Au, Ag and Pt. In a preferred embodiment, the multi-layered composite thin film material is prepared via a facile, green, and easily accessible layer-by-layer (LbL) self-assembly strategy. In this strategy, positively charged GOQDs and negatively charged metal nanocrystals are alternately and uniformly integrated with each other in a “face-to-face” stacked fashion under substantial electrostatic attractive interaction, and then the obtained GOQDs/metal composite thin film is calcined into GQDs/metal composite thin film. The composite thin film material disclosed herein may be used to catalyse a wide range or reactions, including selective reduction of aromatic nitro compounds in water and electrocatalytic oxidation of methanol at ambient conditions.

The invention relates to a catalyst system suitable for hydrogenating aromatic nitro compounds (I) to form the corresponding aromatic amines (II), the catalyst system containing, as essential constituents: a component A selected from the group consisting of silicon carbide, corundum (alpha-Al.sub.2O.sub.3) and slightly porous to non-porous zirconium oxide (ZrO.sub.2); and a component B, containing B1—a carrier substance selected from the group consisting of silicon dioxide, gamma-, delta- or theta-aluminum oxide Al.sub.2O.sub.3, titanium dioxide, zirconium dioxide and graphite, B2—a metal or a plurality of metals selected from the group consisting of copper, nickel, palladium, platinum and cobalt, and optionally B3—an additional metal selected from the group consisting of at least one metal selected from main group I, main group II, main group IV and sub-groups II, V, VI and VIII of the periodic table of the elements, the proportion of component A being in the range of 5 to 60 wt %, in relation to the total weight of the catalyst system, and the aromatic nitro compounds (I) being those of the general formula R—(NO.sub.2).sub.n, (I), and the aromatic amines (II) being those of the general formula R—(NH.sub.2).sub.n, (II), and the moieties R and indices n in formulas (I) and (II) having the following meaning: R is a substituted or unsubstituted aromatic C.sub.6-C.sub.10 moiety and n is an integer from 1 to 5.

The invention relates to a catalyst system suitable for hydrogenating aromatic nitro compounds (I) to form the corresponding aromatic amines (II), the catalyst system containing, as essential constituents: a component A selected from the group consisting of silicon carbide, corundum (alpha-Al.sub.2O.sub.3) and slightly porous to non-porous zirconium oxide (ZrO.sub.2); and a component B, containing B1—a carrier substance selected from the group consisting of silicon dioxide, gamma-, delta- or theta-aluminum oxide Al.sub.2O.sub.3, titanium dioxide, zirconium dioxide and graphite, B2—a metal or a plurality of metals selected from the group consisting of copper, nickel, palladium, platinum and cobalt, and optionally B3—an additional metal selected from the group consisting of at least one metal selected from main group I, main group II, main group IV and sub-groups II, V, VI and VIII of the periodic table of the elements, the proportion of component A being in the range of 5 to 60 wt %, in relation to the total weight of the catalyst system, and the aromatic nitro compounds (I) being those of the general formula R—(NO.sub.2).sub.n, (I), and the aromatic amines (II) being those of the general formula R—(NH.sub.2).sub.n, (II), and the moieties R and indices n in formulas (I) and (II) having the following meaning: R is a substituted or unsubstituted aromatic C.sub.6-C.sub.10 moiety and n is an integer from 1 to 5.

The invention relates to a catalyst system suitable for hydrogenating aromatic nitro compounds (I) to form the corresponding aromatic amines (II), the catalyst system containing, as essential constituents: a component A selected from the group consisting of silicon carbide, corundum (alpha-Al.sub.2O.sub.3) and slightly porous to non-porous zirconium oxide (ZrO.sub.2); and a component B, containing B1—a carrier substance selected from the group consisting of silicon dioxide, gamma-, delta- or theta-aluminum oxide Al.sub.2O.sub.3, titanium dioxide, zirconium dioxide and graphite, B2—a metal or a plurality of metals selected from the group consisting of copper, nickel, palladium, platinum and cobalt, and optionally B3—an additional metal selected from the group consisting of at least one metal selected from main group I, main group II, main group IV and sub-groups II, V, VI and VIII of the periodic table of the elements, the proportion of component A being in the range of 5 to 60 wt %, in relation to the total weight of the catalyst system, and the aromatic nitro compounds (I) being those of the general formula R—(NO.sub.2).sub.n, (I), and the aromatic amines (II) being those of the general formula R—(NH.sub.2).sub.n, (II), and the moieties R and indices n in formulas (I) and (II) having the following meaning: R is a substituted or unsubstituted aromatic C.sub.6-C.sub.10 moiety and n is an integer from 1 to 5.

The present invention relates to a process for continuous hydrogenation of a nitro compound to the corresponding amine in a liquid reaction mixture comprising the nitro compound in a reaction chamber in the presence of a supported catalyst which comprises as the active component at least one element from groups 7 to 12 of the periodic table of the elements, wherein ammonia is added to the reaction chamber during the hydrogenation.

The present invention relates to a process for continuous hydrogenation of a nitro compound to the corresponding amine in a liquid reaction mixture comprising the nitro compound in a reaction chamber in the presence of a supported catalyst which comprises as the active component at least one element from groups 7 to 12 of the periodic table of the elements, wherein ammonia is added to the reaction chamber during the hydrogenation.

The present invention relates to a process for continuous hydrogenation of a nitro compound to the corresponding amine in a liquid reaction mixture comprising the nitro compound in a reaction chamber in the presence of a supported catalyst which comprises as the active component at least one element from groups 7 to 12 of the periodic table of the elements, wherein ammonia is added to the reaction chamber during the hydrogenation.

The present invention relates to processes of preparing N-((1,2,3,4,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-iso-propyl-1H-pyrazole-3-sulfonamide and salts thereof. The present invention further relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

The present invention relates to processes of preparing N-((1,2,3,4,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-iso-propyl-1H-pyrazole-3-sulfonamide and salts thereof. The present invention further relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.